March 25, 2024 — In a groundbreaking medical advancement, three esteemed cardiologists from CLS Health, Dr. Bahaeddin Shabaneh, Dr. Fethi Benraouane, and Dr.

March 25, 2024 — Abbott announced the first patient has been enrolled in the ENVISION investigational device exemption (IDE) clinical trial. The global, randomized trial (

March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the Massachusetts Institute of Technology (MIT) recently announced in the journal Nature Communications that they had successfully built a tissue-like bioelectronic mesh system integrated with an array of atom-thin graphene sensors that can simultaneously measure both the electrical signal and the physical movement of cells in lab-grown human c

March 21, 2024 — Prolocor, Inc., a healthcare startup developing an innovative precision diagnostic test with the goal of predicting the risk of thrombosis by quantifying platelet FcγRIIa (pFCG test), announced the acceptance of its abstract titled Association Between Prognostic Implications of Platelet FCɣRIIA (PFCG) and Treatment Strategy for Myocardial Infarction at The American College of Cardiology (ACC) Scientific Sessions 2024 in Atlanta.

March 21, 2024 — The U.S. Food and Drug Administration (FDA) announced that Abiomed is recalling the Instructions for Use for its Impella Left Sided Blood Pumps because the pump catheter may perforate (cut) the wall of the left ventricle in the heart.

March 21, 2024 — Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of the CIARTIC Move, a mobile C-arm with self-driving capabilities.

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for cardiologists, hands-down. However, it is also one of their biggest challenges. Why is that?

March 20, 2024 — SARS-CoV-2, the virus that causes COVID-19, can damage the heart even without directly infecting

March 20, 2024 — PECA Labs, a medical device company reimagining the field of vascular grafts and valves with durable polymeric cardiovascular devices designed to fit, grow, and last, has received

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now